Cartesian Therapeutics RNAC
NASDAQ RNAC
$6.41 -0.01 (-0.16%)
At close: Oct 22, 2026 · 4:00 PM EDT

Cartesian Therapeutics (RNAC) Other Operating Expenses (2015 - 2025)

Updated

Cartesian Therapeutics' Other Operating Expenses was $56.7 million in Q4 2025, up 648.1% from $7.58 million a year earlier.

Analysis

Cartesian Therapeutics (RNAC) Other Operating Expenses (2015 - 2025) Analysis & Trends

From Q2 2015 onward, Cartesian Therapeutics has reported Other Operating Expenses for 5 quarters.

  • In earlier years, Other Operating Expenses was $7.58 million in FY2024 (+967.5%) and $710,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Cartesian Therapeutics 188.59 Mn -346.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 56.70 Mn
Dec 31, 2024 7.58 Mn
Dec 31, 2023 710,000.00
Jun 30, 2016 64,000.00
Jun 30, 2015 37,000.00
API Access

Cartesian Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=RNAC&period=max&api_key=YOUR_API_KEY